FDA Adverse Event Injury Summary report: N

ESPRIT¿

MDR report key: 24944456 · Received April 21, 2026

Report

Report Number
2024168-2026-01628
Event Type
Injury
Date Received
April 21, 2026
Date of Event
February 27, 2026
Report Date
April 21, 2026
Manufacturer
ABBOTT VASCULAR INC.
Product Code
NXW
UDI-DI
08717648353864
PMA / PMN Number
P230036
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS NOT RETURNED FOR ANALYSIS. PRODUCTION RECORD AND CORRECTIVE AND PREVENTATIVE ACTIONS (CAPA) REVIEWS WERE PERFORMED AND REVEALED NO INDICATION OF A PRODUCT QUALITY ISSUE. ADDITIONALLY, A QUERY OF THE COMPLAINT HANDLING DATABASE FOR THE REPORTED LOT REVEALED THERE IS NO INDICATION OF A LOT SPECIFIC ISSUE. THE REPORTED PATIENT EFFECT OF OCCLUSION IS LISTED IN THE ESPRIT BTK EVEROLIMUS ELUTING RESORBABLE SCAFFOLD SYSTEM OVER-THE-WIRE (OTW) INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY SCAFFOLDING PROCEDURES. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED; HOWEVER, THE SUBSEQUENT TREATMENT APPEARS TO BE RELATED TO THE OPERATIONAL CONTEXT OF THE PROCEDURE. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING; THEREFORE, NO PRODUCT-RELATED CORRECTIVE ACTION WILL BE IMPLEMENTED IN THIS CASE. THE OTHER SCAFFOLDS REFERENCED IN B5 ARE BEING FILED UNDER SEPARATE MEDWATCH REPORT NUMBERS.

Description of Event or Problem · 0

PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2025 THREE ESPRIT OTW SCAFFOLDS (SIZES 2.5X38, 3.0X38 (X2) MM) WERE IMPLANTED IN THE PROXIMAL RIGHT ANTERIOR TIBIAL ARTERY. DURING A FOLLOW-UP APPOINTMENT ON (B)(6) 2026, THE PATIENT HAD BILATERAL CYANOSIS AND NON-PALPABLE PULSES. THE PATIENT WAS SCHEDULED FOR AN ANGIOGRAM TO TREAT A LOWER LIMB ARTERIAL OCCLUSION (STENOSIS) IN ALL THREE INDEX SCAFFOLDS. ON (B)(6) 2026, HE UNDERWENT SUCCESSFUL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF THE TARGET ANTERIOR TIBIAL ARTERY, WHICH IMPROVED FROM 100% STENOSIS TO RESTORED PATENCY AND FLOW. THE PROCEDURE RESTORED PERFUSION WITHOUT COMPLICATION, AND THE PATIENT WAS DISCHARGED IN STABLE CONDITION THE SAME DAY. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
30430 ESPRIT¿ SCAFFOLD,INFRAPOPLITEAL,ABSORBABLE NXW ABBOTT VASCULAR INC. 1212250-38 5050561 08717648353864

Patients

Seq Age Sex Outcome Treatment
1 92 YR Male Hospitalization| R TWO ESPRIT OTW SCAFFOLDS, SIZED 3.0X38 MM